Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Antifungals Stories

2010-03-04 07:00:00

MALVERN, Pa., March 4 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that the most important drug attributes surveyed infectious disease specialists seek in a drug to treat severe Candida infections in the hospital setting are activity against Candida albicans and non-albicans species and fungicidal activity. Candida albicans is the most common species involved in these invasive...

2010-02-01 07:00:00

PALO ALTO, Calif., Feb. 1 /PRNewswire/ -- TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for the use of luliconazole, its lead product candidate, in patients with onychomycosis (nail and nail bed fungal infections). The company plans to initiate a Phase 1/2 trial in the first quarter. Luliconazole is one of the most potent and...

2009-09-14 13:29:00

WOODCLIFF LAKE, N.J., Sept. 14 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that its development partner BioAlliance Pharma SA presented Phase III study results for miconazole Lauriad(R) mucoadhesive buccal tablets (MBT) that demonstrate noninferiority to clotrimazole troches for oropharyngeal candidiasis (OPC), an opportunistic infection of the mouth and throat. The data from this...

2009-08-19 07:00:00

WOODCLIFF LAKE, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad((R)) mucoadhesive buccal tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole MBT delivers the antifungal miconazole via a mucoadhesive buccal tablet...

fda327db0fe5baae9ead463803f6bdb71
2009-08-18 06:20:00

An environmentally friendly alternative to pesticides can be found as close as your herb garden, according to scientists who have spent a decade researching the matter. Researchers decoded the insecticidal properties of rosemary, thyme, clove and mint. The herbs could become a key weapon against insect pests in organic agriculture as the industry tries to satisfy demand. The "plant essential oils" have a broad range of action against bugs: some kill them right away and others repel them....

2009-07-07 11:25:00

CLEVELAND, July 7 /PRNewswire/ -- TREK Diagnostic Systems, a Magellan Biosciences business and premier provider of diagnostic systems and susceptibility products for microbiology labs, has received clearance from the U.S. Food and Drug Administration (FDA) to include caspofungin in its line of YeastOne susceptibility products. TREK will make the drug available on custom YeastOne formats, allowing clinicians to create the plate that best meets their requirements. The custom format complements...

2009-06-02 07:00:00

CORAL GABLES, Fla., June 2 /PRNewswire/ -- Stiefel Laboratories, Inc. announced the completion and analysis of a pivotal phase III clinical trial for Hyphanox(TM) (itraconazole) tablet. The 200 mg itraconazole tablet formulation was developed using the proprietary Meltrex(R) technology. This trial is the largest randomized controlled clinical study in onychomycosis ever undertaken. The study compared once-daily oral dosing of one 200 mg Hyphanox(TM) tablet to two 100 mg capsules of...

2009-05-19 06:37:00

Specially designed microsite (www.meettheburns.com) targets first time athlete's foot sufferers and parents. KENILWORTH, N.J., May 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the arrival of TINACTIN(R) CHILL, an antifungal spray for the treatment of athlete's foot. TINACTIN CHILL is available in two formulations, liquid spray and deodorant powder spray. (Photo: http://www.newscom.com/cgi-bin/prnh/20090519/NY19030 ) To view the Multimedia News...

2009-04-22 07:30:00

PALO ALTO, Calif., April 22 /PRNewswire/ -- TOPICA Pharmaceuticals today announced the enrollment of patients in a Phase 2 clinical trial evaluating luliconazole for the treatment of tinea pedis (athlete's foot). Luliconazole, the company's lead product candidate, is the one of the most potent and broad spectrum molecules in the imidiazole class of antifungal agents, giving it the potential to provide physicians and patients with a needed topical solution to a variety of skin and nail fungal...

2009-03-31 14:38:40

British researchers say tea tree oil is an effective antiseptic, but is even better when mixed with silver. Both the tea tree oils and the silver -- in the form of silver nitrate -- each effectively fight pathogens involved in skin infections in laboratory tests. However, both became even more effective in lower concentrations -- when combined. Bacteria such as Staphylococcus aureus, a common cause of skin infections and abscesses and the yeast Candida albicans -- which causes thrush --...